Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

Since 2016, the FDA has received 25 reports of unapproved epinephrine nasal solution being confused with approved epinephrine injection.

Alcohol use remains one of the most preventable risk factors for cancer. Even moderate alcohol consumption – one or fewer drinks per day – may elevate cancer risk for some types, such as breast, ...

WHO issues statement citing work the United States and WHO have done together and expressing hope for maintaining partnership.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Fractures in nonambulatory children that are not consistent with history or for which no history of injury is given are concerning for abuse ...

The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines. HealthDay News — The Advisory Committee on Immunization Practices ...

After a nurse practitioner was acquitted of illegally prescribing controlled substances, she sues the United States Government and the Drug Enforcement Administration (DEA) Diversion Investigator. The ...

The difference in patient care experience between private equity-acquired and control hospitals increased over time and was largest in postacquisition year 3. Patient-reported care experiences ...

Mirikizumab-treated patients achieved statistically significant clinical remission and endoscopic response compared with placebo at week 52. The Food and Drug Administration (FDA) has approved ...